{"id":"W2014561045","doi":"10.1016/j.ahj.2014.07.028","title":"Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial","year":2014,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":411,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; Canadian VIGOUR Centre","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Alirocumab; PCSK9; Monoclonal; Monoclonal antibody; Term (time); Internal medicine; Intensive care medicine; Antibody; Immunology; Cholesterol; LDL receptor; Lipoprotein","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003149432,0.0002776478,0.00183442,0.0001770746,0.0001993693,0.00002541622,0.0001697231,0.00006173609,0.0000135557],"category_scores_gemma":[0.0004983211,0.0001626186,0.001860475,0.0002741278,0.0001663708,0.00008347458,0.00007336098,0.000344058,0.000004449973],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007710645,"about_ca_system_score_gemma":0.0002177627,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001405235,"about_ca_topic_score_gemma":0.0000017657,"domain_scores_codex":[0.9962209,0.001155235,0.0006065764,0.000299428,0.001377304,0.0003404951],"domain_scores_gemma":[0.9980738,0.0005718302,0.0002381698,0.0007225974,0.0001003867,0.0002931962],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005751569,0.0001912669,0.9490718,0.000152199,0.007567554,0.0001280169,0.0002113944,0.0003741318,0.00229887,0.00001239309,0.0001083029,0.03413245],"study_design_scores_gemma":[0.01794841,0.008878299,0.9677626,0.0003032727,0.001668716,0.001328645,0.00003934313,0.00004195267,0.001586892,0.000008624695,0.0002443334,0.0001889105],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927177,0.0004789316,0.00381918,0.0007489682,0.0004129648,0.001780579,0.000008055753,0.00001449789,0.00001906799],"genre_scores_gemma":[0.9976724,0.00007336736,0.001280368,0.0006713375,0.0001691016,0.00004042231,0.000004702487,0.00003667897,0.00005161055],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03394354,"threshold_uncertainty_score":0.6631395,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02261382628838262,"score_gpt":0.3292959977167019,"score_spread":0.3066821714283193,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}